Butler John P.'s Form 4 filing
Akebia Therapeutics, Inc. (AKBA) · filed Mar 2, 2022
- Accession no.
- 0001562180-22-002166
- Filed
- Mar 2, 2022
- Trade date
- Feb 28-Mar 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $171.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butler John P.CIK 0001591467 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | SSaleDisposed | −25,053 | $2.15 | −$53,863.95 | 1,164,095 | Direct | |
| Feb 28, 2022 | Common Stock | AGrant or awardAcquired | +293,125 | $0.00 | $0 | 1,457,220 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −24,811 | $2.17 | −$53,839.87 | 1,432,409 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −25,031 | $2.17 | −$54,317.27 | 1,407,378 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −4,131 | $2.17 | −$8,964.27 | 1,403,247 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | AGrant or awardAcquired | +739,700 | $0.00 | $0 | 739,700 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.